Drugging the Undruggable RAS in Pancreatic Cancer
Unable to add items
Sorry, we're unable to add the item because your cart is already full.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Failed to remove from Wish List.
Please try again later
Adding to library failed
Please try again
Unable to follow podcast
Unable to unfollow podcast
Drugging the Undruggable RAS in Pancreatic Cancer
-
Narrated by:
-
By:
This summer, a new targeted treatment for pancreatic cancer was approved by the FDA. The treatment, Rasonque (daraxonrasib), is giving new hope to people with a disease that had been seen as almost untreatable. In this episode, Chuck and Alicia unpack this new development with Dr. Brian Wolpin, director of the Hale Family Center for Pancreatic Cancer Research at Dana-Farber Cancer Institute, who led the drug trial.
adbl_web_anon_alc_button_suppression_t1
No reviews yet